Myron Kaplan bought $276K of CorMedix (CRMD)

Executed Oct 23 2025, disclosed Oct 28 2025, 4 days later.

Value, as filed

$276K

25,000 sh × $11.02

Executed

Oct 23 2025

the trade date, as filed

Disclosed

Oct 28 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-13.1%

-14.0% from execution

Over the 21 trading sessions from the disclosed entry session (Oct 27 2025), the stock returned -13.1% (delay-adjusted); from the execution session (Oct 23 2025), -14.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

MK Myron Kaplan Director profile →

Myron Kaplan (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in CRMD. Across 1 priced purchase filing, the average 21-session return was -14.0% from execution and -13.1% from disclosure (delay-adjusted; derived). The largest single filing was $276K of CRMD (25,000 sh × $11.02, as filed), executed Oct 23 2025.

The name

CRMD CRMD CRMD · 13 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→